Products
- - Products Image
- - Products
  - APIs
  - R&D PIPELINE
Services
Company
- - Company Image
- - Company
  - ABOUT US
  - NETWORK
  - CAREERS
News
Contact

Month: July 2024

C2 PHARMA Receives CEP Approval For Tropicamide

Posted on 30. July 202430. July 2024 by admin_c2p

Posted in Press Release

Search for:

Recent Posts

C2 PHARMA Marks 10th Year Anniversary Attendance at CPhI Milan with Expanded Ophthalmic API Portfolio
C2 PHARMA EXPANDS OPHTHALMIC API PORTFOLIO WITH NAPHAZOLINE HYDROCHLORIDE LAUNCH
C2 PHARMA Receives CEP Approval For Tropicamide
C2 PHARMA’s Upcoming Launch of Oxybuprocaine Hydrochloride
C2 PHARMA x PharmaSource Ophthalmics Buyer Guide

Archives

Categories

General
Information Brief
podcast
Press Release
Video

Meta

Log in
Entries feed
Comments feed
WordPress.org

APIs

R&D Pipeline
Services
About Us
Network
Careers
News

CONTACT

info@c2pharma.com

General Terms of Sales
Data Privacy